Does Evaluation and Management of COPD Follow Therapeutic Strategy Recommendations?

Fernando J Martinez, Byron Thomashow, Tamar Sapir, Laura Simone, Jeffrey Carter, MeiLan Han
Author Information
  1. Fernando J Martinez: Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York, United States.
  2. Byron Thomashow: Columbia University, New York Presbyterian Hospital, New York, New York, United States.
  3. Tamar Sapir: PRIME Education, LLC, Fort Lauderdale, Florida, United States.
  4. Laura Simone: PRIME Education, LLC, Fort Lauderdale, Florida, United States.
  5. Jeffrey Carter: PRIME Education, LLC, Fort Lauderdale, Florida, United States.
  6. MeiLan Han: University of Michigan Health System, Ann Arbor, Michigan, United States.

Abstract

INTRODUCTION: Recommendations for chronic obstructive pulmonary disease (COPD) diagnosis and management requires symptom and exacerbation risk assessment. Adherence to these recommendations appears to be limited. We examined the impact of a COPD quality improvement (QI) program in the Southeastern United States.
METHODS: From 2017 to 2018, nine pulmonary and 15 primary care physicians were included in our study and asked to identify 6 to 7 of their COPD patients using maintenance COPD medications with at least 2 office visits in the past year. A separate group of COPD patients (n=135 pulmonary and 165 primary care) from the same practices were evaluated. Physicians underwent focused, educational, peer-to-peer small group webinars. Data were collected from physicians and their patients using a systematic survey. Chart audits occurred at baseline and 6 months after the webinars.
RESULTS: The majority of physicians (67%) saw ≥ 20 COPD patients/week. There were important discrepancies between the care clinicians thought they provided, and the care recalled by their patients. Clinicians felt that 33% of their patients experienced at least 2 exacerbations in the past year; 56% of their patients reported this frequency. There was discrepancy in the clinicians' interpretations and the patients' reasons for discontinuing their medications and in the use of referrals. Self-reported changes were noted by clinicians after educational webinars and improvements in patient care were noted in the year following intervention.
CONCLUSION: We identified notable discrepancies between the clinicians' impression of care provided and the components actually recalled by their patients. We also identified improvements in processes of care and outcomes following an educational intervention based on the principles of audit and feedback.

Keywords

References

  1. Chonnam Med J. 2019 Jan;55(1):47-53 [PMID: 30740340]
  2. Chronic Obstr Pulm Dis. 2019 Jul 24;6(3):210-220 [PMID: 31075813]
  3. Healthcare (Basel). 2018 Jul 25;6(3): [PMID: 30044381]
  4. NPJ Prim Care Respir Med. 2018 Mar 23;28(1):10 [PMID: 29572448]
  5. Int J Tuberc Lung Dis. 2009 Mar;13(3):387-93 [PMID: 19275802]
  6. Int J Chron Obstruct Pulmon Dis. 2014 Dec 30;10:39-55 [PMID: 25565799]
  7. BMC Med Res Methodol. 2018 Jul 3;18(1):68 [PMID: 29970023]
  8. Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582 [PMID: 28128970]
  9. BMC Pulm Med. 2014 Aug 07;14:131 [PMID: 25098313]
  10. Curr Med Res Opin. 2013 Aug;29(8):957-66 [PMID: 23663130]
  11. Inflamm Bowel Dis. 2015 Sep;21(9):2165-71 [PMID: 26020603]
  12. Respir Med. 2013 Jul;107(7):1046-52 [PMID: 23639271]
  13. J Am Med Dir Assoc. 2019 Oct;20(10):1313-1317.e9 [PMID: 30852169]
  14. Ann Am Thorac Soc. 2019 Feb;16(2):200-208 [PMID: 30216731]
  15. Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65 [PMID: 22878278]
  16. BMC Pulm Med. 2018 Dec 20;18(1):195 [PMID: 30572869]
  17. PLoS One. 2016 Mar 17;11(3):e0151896 [PMID: 26985822]
  18. Int J Chron Obstruct Pulmon Dis. 2018 Aug 15;13:2455-2462 [PMID: 30147311]
  19. Int J Chron Obstruct Pulmon Dis. 2017 Nov 28;12:3371-3379 [PMID: 29238182]
  20. Respir Med. 2012 Mar;106(3):374-81 [PMID: 22000501]
  21. Eur Respir J. 2019 May 18;53(5): [PMID: 30846476]
  22. Health Qual Life Outcomes. 2003 Apr 28;1:13 [PMID: 12773199]
  23. Int J Chron Obstruct Pulmon Dis. 2018 Oct 23;13:3485-3492 [PMID: 30498338]
  24. Int J Chron Obstruct Pulmon Dis. 2011;6:171-9 [PMID: 21468169]
  25. J Prim Care Community Health. 2013 Jul 1;4(3):172-6 [PMID: 23799703]
  26. Praxis (Bern 1994). 2015 Aug 19;104(17):897-907 [PMID: 26286494]
  27. SAGE Open Med. 2019 Apr 04;7:2050312119842221 [PMID: 31057794]
  28. Rheumatol Ther. 2015 Dec;2(2):141-151 [PMID: 27747535]
  29. Int J Chron Obstruct Pulmon Dis. 2018 Sep 25;13:2949-2959 [PMID: 30310271]
  30. Lancet. 2015 May 2;385(9979):1789-1798 [PMID: 25943943]
  31. NPJ Prim Care Respir Med. 2014 Jul 10;24:14021 [PMID: 25010353]

Grants

  1. /AstraZeneca LP

Word Cloud

Created with Highcharts 10.0.0COPDcarepatientspulmonaryphysiciansyeareducationalwebinarsprimary6usingmedicationsleast2pastgroupdiscrepanciescliniciansprovidedrecalledclinicians'notedimprovementsfollowinginterventionidentifiedINTRODUCTION:RecommendationschronicobstructivediseasediagnosismanagementrequiressymptomexacerbationriskassessmentAdherencerecommendationsappearslimitedexaminedimpactqualityimprovementQIprogramSoutheasternUnitedStatesMETHODS:20172018nine15includedstudyaskedidentify7maintenanceofficevisitsseparaten=135165practicesevaluatedPhysiciansunderwentfocusedpeer-to-peersmallDatacollectedsystematicsurveyChartauditsoccurredbaselinemonthsRESULTS:majority67%saw20patients/weekimportantthoughtCliniciansfelt33%experiencedexacerbations56%reportedfrequencydiscrepancyinterpretationspatients'reasonsdiscontinuingusereferralsSelf-reportedchangespatientCONCLUSION:notableimpressioncomponentsactuallyalsoprocessesoutcomesbasedprinciplesauditfeedbackEvaluationManagementFollowTherapeuticStrategyRecommendations?COPDadherenceevaluationtherapeuticstrategy

Similar Articles

Cited By (1)